5T4-modified vaccinia ankara: progress in tumor-associated antigen-based immunotherapy

By Amato Robert J  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 9, 2007-09 ,pp. : 1463-1469

Informa Healthcare

Access to resources Recommend Favorite

In vitro mimicry of CaMBr1 tumor-associated antigen by synthetic oligosaccharides

By Adobati Elena   Panza Luigi   Russo Giovanni   Colnaghi Maria I.   Canevari Silvana  

Glycobiology, Vol. 7, Iss. 2, 1997-02 ,pp. : 173-178

Oxford University Press

Access to resources Recommend Favorite

Cloning and Characterization of a Tumor-Associated Antigen, β-Casein-like Protein

By Baba T.   Koizumi M.   Suzuki T.   Yamanaka I.   Yamashita S.   Kudo R.  

Biochemical and Biophysical Research Communications, Vol. 284, Iss. 2, 2001-06 ,pp. : 340-345

Elsevier

Access to resources Recommend Favorite

Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?

By Dillman Robert O   Cornforth Andrew N   Nistor Gabriel  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 643-656

Informa Healthcare

Access to resources Recommend Favorite

Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer

By Ochi Toshiki   Fujiwara Hiroshi   Yasukawa Masaki  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 699-713

Informa Healthcare

Access to resources Recommend Favorite